Last 12 months
Inside the activity.
0 purchase rows · 20 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 6 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 07, 2020 Filed May 11, 2020 20:19 UTC |
Kauffman MichaelDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 7,500 | $4.75 | $35,640.00 |
DisclosureSEC source: 0001209191-20-028261 · doc4.xml · nonDerivative · entry 1 Kauffman Michael · CIK 0001364719 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 562,622 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| May 07, 2020 Filed May 11, 2020 20:26 UTC |
Frenkel RanChief Dev Operations Officer
|
SaleCommon Stock | 1,974 | $20.00 | $39,480.00 |
DisclosureSEC source: 0001209191-20-028271 · doc4.xml · nonDerivative · entry 1 Frenkel Ran · CIK 0001623108 · Chief Dev Operations Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,088 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · balance_after: Includes 996 shares acquired under the Karyopharm Therapeutics Inc. 2013 Employee Stock Purchase Plan. Read SEC document |
| May 07, 2020 Filed May 11, 2020 20:22 UTC |
Shacham SharonPresident & CSO
|
Exercise / conversionStock Option (right to buy) · Derivative | 7,500 | $0.00 Strike: $4.75 | $0.00 |
DisclosureSEC source: 0001209191-20-028263 · doc4.xml · derivative · entry 6 Shacham Sharon · CIK 0001588438 · President & CSO 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 348,561 Underlying: Common Stock · 7,500 shares Expires 2023-09-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the spouse of the reporting person. F5 · derivative.exercise_date: This option, representing a right to purchase a specified number of shares, vested as to 25% of the shares on September 3, 2014, and the remaining 75% vested in 36 equal monthly installments thereafter. Read SEC document |
| May 07, 2020 Filed May 11, 2020 20:22 UTC |
Shacham SharonPresident & CSO
|
Exercise / conversionStock Option (right to buy) · Derivative | 7,500 | $0.00 Strike: $4.75 | $0.00 |
DisclosureSEC source: 0001209191-20-028263 · doc4.xml · derivative · entry 5 Shacham Sharon · CIK 0001588438 · President & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 392,803 Underlying: Common Stock · 7,500 shares Expires 2023-09-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F5 · derivative.exercise_date: This option, representing a right to purchase a specified number of shares, vested as to 25% of the shares on September 3, 2014, and the remaining 75% vested in 36 equal monthly installments thereafter. Read SEC document |
| May 07, 2020 Filed May 11, 2020 20:22 UTC |
Shacham SharonPresident & CSO
|
SaleCommon Stock | 7,500 | $19.63 | $147,209.25 |
DisclosureSEC source: 0001209191-20-028263 · doc4.xml · nonDerivative · entry 4 Shacham Sharon · CIK 0001588438 · President & CSO 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 555,122 F3 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the spouse of the reporting person. F4 · price: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $19.49 to $20.00, inclusive. The spouse of the reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 07, 2020 Filed May 11, 2020 20:22 UTC |
Shacham SharonPresident & CSO
|
Exercise / conversionCommon Stock | 7,500 | $4.75 | $35,640.00 |
DisclosureSEC source: 0001209191-20-028263 · doc4.xml · nonDerivative · entry 3 Shacham Sharon · CIK 0001588438 · President & CSO 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 562,622 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the spouse of the reporting person. Read SEC document |
| May 07, 2020 Filed May 11, 2020 20:22 UTC |
Shacham SharonPresident & CSO
|
SaleCommon Stock | 7,500 | $19.63 | $147,204.75 |
DisclosureSEC source: 0001209191-20-028263 · doc4.xml · nonDerivative · entry 2 Shacham Sharon · CIK 0001588438 · President & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 756,489 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $19.49 to $20.00, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 07, 2020 Filed May 11, 2020 20:22 UTC |
Shacham SharonPresident & CSO
|
Exercise / conversionCommon Stock | 7,500 | $4.75 | $35,640.00 |
DisclosureSEC source: 0001209191-20-028263 · doc4.xml · nonDerivative · entry 1 Shacham Sharon · CIK 0001588438 · President & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 763,989 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| April 09, 2020 Filed Apr 10, 2020 21:09 UTC |
Kauffman MichaelDirector · Chief Executive Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $4.75 | $0.00 |
DisclosureSEC source: 0001209191-20-024148 · doc4.xml · derivative · entry 5 Kauffman Michael · CIK 0001364719 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 356,061 Underlying: Common Stock · 10,000 shares Expires 2023-09-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F5 · derivative.exercise_date: This option, representing a right to purchase a specified number of shares, vested as to 25% of the shares on September 3, 2014, and the remaining 75% vested in 36 equal monthly installments thereafter. Read SEC document |
| April 09, 2020 Filed Apr 10, 2020 21:09 UTC |
Kauffman MichaelDirector · Chief Executive Officer
|
SaleCommon Stock | 10,000 | $20.64 | $206,404.00 |
DisclosureSEC source: 0001209191-20-024148 · doc4.xml · nonDerivative · entry 2 Kauffman Michael · CIK 0001364719 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 555,122 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $20.36 to $20.99, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| April 09, 2020 Filed Apr 10, 2020 21:09 UTC |
Kauffman MichaelDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 10,000 | $4.75 | $47,520.00 |
DisclosureSEC source: 0001209191-20-024148 · doc4.xml · nonDerivative · entry 1 Kauffman Michael · CIK 0001364719 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 565,122 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| April 09, 2020 Filed Apr 10, 2020 21:06 UTC |
Shacham SharonPresident & CSO
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $4.75 | $0.00 |
DisclosureSEC source: 0001209191-20-024147 · doc4.xml · derivative · entry 6 Shacham Sharon · CIK 0001588438 · President & CSO 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 356,061 Underlying: Common Stock · 10,000 shares Expires 2023-09-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the spouse of the reporting person. F5 · derivative.exercise_date: This option, representing a right to purchase a specified number of shares, vested as to 25% of the shares on September 3, 2014, and the remaining 75% vested in 36 equal monthly installments thereafter. Read SEC document |
| April 09, 2020 Filed Apr 10, 2020 21:06 UTC |
Shacham SharonPresident & CSO
|
SaleCommon Stock | 10,000 | $20.64 | $206,404.00 |
DisclosureSEC source: 0001209191-20-024147 · doc4.xml · nonDerivative · entry 4 Shacham Sharon · CIK 0001588438 · President & CSO 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 555,122 F3 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the spouse of the reporting person. F4 · price: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $20.36 to $20.99, inclusive. The spouse of the reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| April 09, 2020 Filed Apr 10, 2020 21:06 UTC |
Shacham SharonPresident & CSO
|
Exercise / conversionCommon Stock | 10,000 | $4.75 | $47,520.00 |
DisclosureSEC source: 0001209191-20-024147 · doc4.xml · nonDerivative · entry 3 Shacham Sharon · CIK 0001588438 · President & CSO 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 565,122 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the spouse of the reporting person. Read SEC document |
| April 08, 2020 Filed Apr 10, 2020 21:09 UTC |
Kauffman MichaelDirector · Chief Executive Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $4.75 | $0.00 |
DisclosureSEC source: 0001209191-20-024148 · doc4.xml · derivative · entry 6 Kauffman Michael · CIK 0001364719 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 400,303 Underlying: Common Stock · 10,000 shares Expires 2023-09-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the spouse of the reporting person. F5 · derivative.exercise_date: This option, representing a right to purchase a specified number of shares, vested as to 25% of the shares on September 3, 2014, and the remaining 75% vested in 36 equal monthly installments thereafter. Read SEC document |
| April 08, 2020 Filed Apr 10, 2020 21:09 UTC |
Kauffman MichaelDirector · Chief Executive Officer
|
SaleCommon Stock | 10,000 | $18.61 | $186,115.00 |
DisclosureSEC source: 0001209191-20-024148 · doc4.xml · nonDerivative · entry 4 Kauffman Michael · CIK 0001364719 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 756,489 F3 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the spouse of the reporting person. F4 · price: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $18.15 to $19.06, inclusive. The spouse of the reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| April 08, 2020 Filed Apr 10, 2020 21:09 UTC |
Kauffman MichaelDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 10,000 | $4.75 | $47,520.00 |
DisclosureSEC source: 0001209191-20-024148 · doc4.xml · nonDerivative · entry 3 Kauffman Michael · CIK 0001364719 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 766,489 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the spouse of the reporting person. Read SEC document |
| April 08, 2020 Filed Apr 10, 2020 21:06 UTC |
Shacham SharonPresident & CSO
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $4.75 | $0.00 |
DisclosureSEC source: 0001209191-20-024147 · doc4.xml · derivative · entry 5 Shacham Sharon · CIK 0001588438 · President & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,303 Underlying: Common Stock · 10,000 shares Expires 2023-09-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F5 · derivative.exercise_date: This option, representing a right to purchase a specified number of shares, vested as to 25% of the shares on September 3, 2014, and the remaining 75% vested in 36 equal monthly installments thereafter. Read SEC document |
| April 08, 2020 Filed Apr 10, 2020 21:06 UTC |
Shacham SharonPresident & CSO
|
SaleCommon Stock | 10,000 | $18.61 | $186,115.00 |
DisclosureSEC source: 0001209191-20-024147 · doc4.xml · nonDerivative · entry 2 Shacham Sharon · CIK 0001588438 · President & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 756,489 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $18.15 to $19.06, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| April 08, 2020 Filed Apr 10, 2020 21:06 UTC |
Shacham SharonPresident & CSO
|
Exercise / conversionCommon Stock | 10,000 | $4.75 | $47,520.00 |
DisclosureSEC source: 0001209191-20-024147 · doc4.xml · nonDerivative · entry 1 Shacham Sharon · CIK 0001588438 · President & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 766,489 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| March 16, 2020 Filed Mar 17, 2020 17:30 UTC |
DEMAREE JOHNChief Commercial Officer
|
GrantNonstatutory Stock Option (right to buy) · Derivative | 151,200 | $0.00 Strike: $16.50 | $0.00 |
DisclosureSEC source: 0001209191-20-019703 · doc4.xml · derivative · entry 1 DEMAREE JOHN · CIK 0001744959 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,200 Underlying: Common Stock · 151,200 shares Expires 2030-03-15 F1 · derivative.exercise_date: This option was granted on March 16, 2020. The shares underlying this option vest as to 25% of the shares on March 16, 2021, with the remaining 75% vesting in 36 equal monthly installments thereafter. Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 21:35 UTC |
Greene Barry EDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 3,030 | $0.00 Strike: $0.03 | $0.00 |
DisclosureSEC source: 0001209191-20-019709 · doc4.xml · derivative · entry 2 Greene Barry E · CIK 0001291963 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,030 shares Expires 2021-04-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option representing a right to purchase a specified number of shares vested as to 25% of the shares on April 14, 2012, and the remaining 75% vested in 36 equal monthly installments thereafter. Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 21:35 UTC |
Greene Barry EDirector
|
Exercise / conversionCommon Stock | 3,030 | $0.03 | $99.99 |
DisclosureSEC source: 0001209191-20-019709 · doc4.xml · nonDerivative · entry 1 Greene Barry E · CIK 0001291963 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,030 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 10, 2020 Filed Mar 11, 2020 23:07 UTC |
Kauffman MichaelDirector · Chief Executive Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $4.75 | $0.00 |
DisclosureSEC source: 0001209191-20-018258 · doc4.xml · derivative · entry 7 Kauffman Michael · CIK 0001364719 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 366,061 Underlying: Common Stock · 10,000 shares Expires 2023-09-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F7 · derivative.exercise_date: This option, representing a right to purchase a specified number of shares, vested as to 25% of the shares on September 3, 2014, and the remaining 75% vested in 36 equal monthly installments thereafter. Read SEC document |
| March 10, 2020 Filed Mar 11, 2020 23:07 UTC |
Kauffman MichaelDirector · Chief Executive Officer
|
SaleCommon Stock | 2,068 | $22.64 | $46,820.55 |
DisclosureSEC source: 0001209191-20-018258 · doc4.xml · nonDerivative · entry 3 Kauffman Michael · CIK 0001364719 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 555,122 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $22.575 to $22.76, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 10, 2020 Filed Mar 11, 2020 23:07 UTC |
Kauffman MichaelDirector · Chief Executive Officer
|
SaleCommon Stock | 7,932 | $22.11 | $175,365.42 |
DisclosureSEC source: 0001209191-20-018258 · doc4.xml · nonDerivative · entry 2 Kauffman Michael · CIK 0001364719 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 557,190 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $21.57 to $22.55, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 10, 2020 Filed Mar 11, 2020 23:07 UTC |
Kauffman MichaelDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 10,000 | $4.75 | $47,520.00 |
DisclosureSEC source: 0001209191-20-018258 · doc4.xml · nonDerivative · entry 1 Kauffman Michael · CIK 0001364719 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 565,122 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| March 10, 2020 Filed Mar 11, 2020 23:10 UTC |
Shacham SharonPresident & CSO
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $4.75 | $0.00 |
DisclosureSEC source: 0001209191-20-018260 · doc4.xml · derivative · entry 8 Shacham Sharon · CIK 0001588438 · President & CSO 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 366,061 Underlying: Common Stock · 10,000 shares Expires 2023-09-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the spouse of the reporting person. F7 · derivative.exercise_date: This option, representing a right to purchase a specified number of shares, vested as to 25% of the shares on September 3, 2014, and the remaining 75% vested in 36 equal monthly installments thereafter. Read SEC document |
| March 10, 2020 Filed Mar 11, 2020 23:10 UTC |
Shacham SharonPresident & CSO
|
SaleCommon Stock | 2,068 | $22.64 | $46,820.55 |
DisclosureSEC source: 0001209191-20-018260 · doc4.xml · nonDerivative · entry 6 Shacham Sharon · CIK 0001588438 · President & CSO 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 555,122 F4 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the spouse of the reporting person. F6 · price: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $22.575 to $22.76, inclusive. The spouse of the reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 10, 2020 Filed Mar 11, 2020 23:10 UTC |
Shacham SharonPresident & CSO
|
SaleCommon Stock | 7,932 | $22.11 | $175,365.42 |
DisclosureSEC source: 0001209191-20-018260 · doc4.xml · nonDerivative · entry 5 Shacham Sharon · CIK 0001588438 · President & CSO 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 557,190 F4 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the spouse of the reporting person. F5 · price: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $21.57 to $22.55, inclusive. The spouse of the reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 10, 2020 Filed Mar 11, 2020 23:10 UTC |
Shacham SharonPresident & CSO
|
Exercise / conversionCommon Stock | 10,000 | $4.75 | $47,520.00 |
DisclosureSEC source: 0001209191-20-018260 · doc4.xml · nonDerivative · entry 4 Shacham Sharon · CIK 0001588438 · President & CSO 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 565,122 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the spouse of the reporting person. Read SEC document |
| March 09, 2020 Filed Mar 11, 2020 23:07 UTC |
Kauffman MichaelDirector · Chief Executive Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $4.75 | $0.00 |
DisclosureSEC source: 0001209191-20-018258 · doc4.xml · derivative · entry 8 Kauffman Michael · CIK 0001364719 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 410,303 Underlying: Common Stock · 10,000 shares Expires 2023-09-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the spouse of the reporting person. F7 · derivative.exercise_date: This option, representing a right to purchase a specified number of shares, vested as to 25% of the shares on September 3, 2014, and the remaining 75% vested in 36 equal monthly installments thereafter. Read SEC document |
| March 09, 2020 Filed Mar 11, 2020 23:07 UTC |
Kauffman MichaelDirector · Chief Executive Officer
|
SaleCommon Stock | 3,000 | $22.38 | $67,140.90 |
DisclosureSEC source: 0001209191-20-018258 · doc4.xml · nonDerivative · entry 6 Kauffman Michael · CIK 0001364719 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 756,489 F4 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the spouse of the reporting person. F6 · price: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $23.05 to $23.75, inclusive. The spouse of the reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 09, 2020 Filed Mar 11, 2020 23:07 UTC |
Kauffman MichaelDirector · Chief Executive Officer
|
SaleCommon Stock | 7,000 | $22.58 | $158,053.70 |
DisclosureSEC source: 0001209191-20-018258 · doc4.xml · nonDerivative · entry 5 Kauffman Michael · CIK 0001364719 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 759,489 F4 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the spouse of the reporting person. F5 · price: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $22.095 to $23.04, inclusive. The spouse of the reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 09, 2020 Filed Mar 11, 2020 23:07 UTC |
Kauffman MichaelDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 10,000 | $4.75 | $47,520.00 |
DisclosureSEC source: 0001209191-20-018258 · doc4.xml · nonDerivative · entry 4 Kauffman Michael · CIK 0001364719 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 766,489 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the spouse of the reporting person. Read SEC document |
| March 09, 2020 Filed Mar 11, 2020 23:10 UTC |
Shacham SharonPresident & CSO
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $4.75 | $0.00 |
DisclosureSEC source: 0001209191-20-018260 · doc4.xml · derivative · entry 7 Shacham Sharon · CIK 0001588438 · President & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 410,303 Underlying: Common Stock · 10,000 shares Expires 2023-09-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F7 · derivative.exercise_date: This option, representing a right to purchase a specified number of shares, vested as to 25% of the shares on September 3, 2014, and the remaining 75% vested in 36 equal monthly installments thereafter. Read SEC document |
| March 09, 2020 Filed Mar 11, 2020 23:10 UTC |
Shacham SharonPresident & CSO
|
SaleCommon Stock | 3,000 | $22.38 | $67,140.90 |
DisclosureSEC source: 0001209191-20-018260 · doc4.xml · nonDerivative · entry 3 Shacham Sharon · CIK 0001588438 · President & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 756,489 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $23.05 to $23.75, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 09, 2020 Filed Mar 11, 2020 23:10 UTC |
Shacham SharonPresident & CSO
|
SaleCommon Stock | 7,000 | $22.58 | $158,053.70 |
DisclosureSEC source: 0001209191-20-018260 · doc4.xml · nonDerivative · entry 2 Shacham Sharon · CIK 0001588438 · President & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 759,489 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $22.095 to $23.04, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 09, 2020 Filed Mar 11, 2020 23:10 UTC |
Shacham SharonPresident & CSO
|
Exercise / conversionCommon Stock | 10,000 | $4.75 | $47,520.00 |
DisclosureSEC source: 0001209191-20-018260 · doc4.xml · nonDerivative · entry 1 Shacham Sharon · CIK 0001588438 · President & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 766,489 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| March 05, 2020 Filed Mar 9, 2020 21:11 UTC |
Paulson Richard A.Director
|
GrantNonstatutory Stock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $26.12 | $0.00 |
DisclosureSEC source: 0001209191-20-017361 · doc4.xml · derivative · entry 1 Paulson Richard A. · CIK 0001804460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2030-03-04 F1 · derivative.exercise_date: This option was granted on March 5, 2020. The shares underlying this option vest as to one-third (1/3) of the shares on March 5, 2021 and as to the remaining two-thirds (2/3) of the shares in 24 equal monthly installments thereafter. Read SEC document |
| March 02, 2020 Filed Mar 5, 2020 01:33 UTC |
Primiano Christopher BrettEVP, CBO, GC & Secretary
|
Exercise / conversionStock Option (right to buy) · Derivative | 26,500 | $0.00 Strike: $10.39 | $0.00 |
DisclosureSEC source: 0001209191-20-016416 · doc4.xml · derivative · entry 5 Primiano Christopher Brett · CIK 0001603510 · EVP, CBO, GC & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,500 Underlying: Common Stock · 26,500 shares Expires 2027-01-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · derivative.exercise_date: This option, representing a right to purchase a specified number of shares, vested as to 25% of the shares on January 20, 2018, with the remaining 75% vesting in 36 equal monthly installments thereafter. Read SEC document |
| March 02, 2020 Filed Mar 5, 2020 01:33 UTC |
Primiano Christopher BrettEVP, CBO, GC & Secretary
|
SaleCommon Stock | 9,000 | $24.00 | $216,028.80 |
DisclosureSEC source: 0001209191-20-016416 · doc4.xml · nonDerivative · entry 4 Primiano Christopher Brett · CIK 0001603510 · EVP, CBO, GC & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,367 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $24.00 to $24.04, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 02, 2020 Filed Mar 5, 2020 01:33 UTC |
Primiano Christopher BrettEVP, CBO, GC & Secretary
|
SaleCommon Stock | 10,000 | $28.00 | $280,000.00 |
DisclosureSEC source: 0001209191-20-016416 · doc4.xml · nonDerivative · entry 3 Primiano Christopher Brett · CIK 0001603510 · EVP, CBO, GC & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,367 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| March 02, 2020 Filed Mar 5, 2020 01:33 UTC |
Primiano Christopher BrettEVP, CBO, GC & Secretary
|
SaleCommon Stock | 7,500 | $23.50 | $176,250.00 |
DisclosureSEC source: 0001209191-20-016416 · doc4.xml · nonDerivative · entry 2 Primiano Christopher Brett · CIK 0001603510 · EVP, CBO, GC & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,367 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| March 02, 2020 Filed Mar 5, 2020 01:33 UTC |
Primiano Christopher BrettEVP, CBO, GC & Secretary
|
Exercise / conversionCommon Stock | 26,500 | $10.39 | $275,335.00 |
DisclosureSEC source: 0001209191-20-016416 · doc4.xml · nonDerivative · entry 1 Primiano Christopher Brett · CIK 0001603510 · EVP, CBO, GC & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,867 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 23:51 UTC |
Mirza Mansoor RazaDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $8.06 | $0.00 |
DisclosureSEC source: 0001209191-20-016347 · doc4.xml · derivative · entry 3 Mirza Mansoor Raza · CIK 0001588389 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2026-06-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · derivative.exercise_date: This option, representing a right to purchase a specified number of shares, vested as to 100% of the underlying shares on June 16, 2017. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 23:51 UTC |
Mirza Mansoor RazaDirector
|
SaleCommon Stock | 5,000 | $23.50 | $117,500.00 |
DisclosureSEC source: 0001209191-20-016347 · doc4.xml · nonDerivative · entry 2 Mirza Mansoor Raza · CIK 0001588389 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 23:51 UTC |
Mirza Mansoor RazaDirector
|
Exercise / conversionCommon Stock | 5,000 | $8.06 | $40,300.00 |
DisclosureSEC source: 0001209191-20-016347 · doc4.xml · nonDerivative · entry 1 Mirza Mansoor Raza · CIK 0001588389 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 22:53 UTC |
Kauffman MichaelDirector · Chief Executive Officer
|
SaleCommon Stock | 8,817 | $16.48 | $145,320.91 |
DisclosureSEC source: 0001209191-20-011687 · doc4.xml · nonDerivative · entry 2 Kauffman Michael · CIK 0001364719 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 756,489 F3 · kind: This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the spouse of the reporting person. F4 · price: The sale price of the spouse of the reporting person's shares represents the weighted average price of all shares sold by a broker on February 19, 2020 on behalf of a group of employees of Karyopharm Therapeutics Inc. to satisfy the payment of withholding tax liability of such employees. Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 22:53 UTC |
Kauffman MichaelDirector · Chief Executive Officer
|
SaleCommon Stock | 8,817 | $16.48 | $145,320.91 |
DisclosureSEC source: 0001209191-20-011687 · doc4.xml · nonDerivative · entry 1 Kauffman Michael · CIK 0001364719 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 555,122 F1 · kind: This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the reporting person. F2 · price: The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on February 19, 2020 on behalf of a group of employees of Karyopharm Therapeutics Inc. to satisfy the payment of withholding tax liability of such employees. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.